Download this datacard
Overview
Lobbying Costs
800,000€ - 899,999€
Financial year: Jan 2023 - Dec 2023
Lobbyists (Full time equivalent)
4 Fte (8)
Lobbyists with EP accreditation
7
High-level Commission meetings
22
Lobbying Costs over the years
-
Info
European Confederation of Pharmaceutical Entrepreneurs (EUCOPE)
EU Transparency Register
87600691525-93 First registered on 15 Apr 2009
Goals / Remit
The European Confederation for Pharmaceutical Entrepreneurs (EUCOPE) is the voice of small to medium-sized innovative companies in the fields of pharmaceuticals, biotechnologies and medical devices. Via its member associations such as the German Pharmaceutical Industry Association (BPI), the British Ethical Medicines Industry Group (EMIG), France Biotech and the Swedish Association IML, EUCOPE represents over 900 member companies. Corporate members include innovative family-owned companies and companies active in the field of rare diseases.
EUCOPE furthers its members' scientific, technical, economic and legal objectives and represents them towards national and international governmental organisations, in particular towards the EU institutions and agencies.Main EU files targeted
Any legislative proposal or policy related to or affecting healthcare/public health/life sciences, in particular the general legal framework for medicinal products and medical devices as well as orphan medicinal products, substances of human origin, EU HTA and paediatrics.
Industrial Strategy.
Trade.
The main EU legislative proposals, policies or files EUCOPE is engaged with are the below (this is not an exhaustive list):
A Pharmaceutical Strategy for Europe
Orphan Medicinal Products Regulation
Paediatrics Regulation
Directive 2001/83/EC on the Community code relating to medicinal products for human use
Regulation No 726/2004 laying down Union procedures for the authorisation and supervision of medicinal products for human use and establishing a European Medicines Agency
Substances of Human Origins Regulation
ATMPs Regulation
Clinical Trials Regulation
EU Regulation on health technology assessment
European Health Data Space
HERA Regulation
Cross-border healthcare directiveAddress
Head Office
rue Marie de Bourgogne 58
Brussels 1000
BELGIUMEU Office
rue Marie de Bourgogne 58
Brussels 1000
BELGIUMWebsite
-
People
Total lobbyists declared
8
Employment time Lobbyists 75% 2 50% 4 25% 2 Lobbyists (Full time equivalent)
4
Lobbyists with EP accreditation
All Lobbyists with EP accreditation over time
7 accreditations were / are live (in bold) for the selected state of 21 Nov 2024
Name Start date End Date Cécile Francine Madeleine Etevenot 09 Sep 2024 08 Sep 2025 Alexander Werner Dr. Natz 09 Sep 2024 08 Sep 2025 Oliver Sude 10 Jul 2024 10 Jul 2025 Stefania ALESSI 10 Jul 2024 10 Jul 2025 Stefano ROMANELLi 02 Oct 2024 01 Oct 2025 Matias OLSEN 09 Sep 2024 08 Sep 2025 Victor MAERTENS 10 Jul 2024 10 Jul 2025 Stefano ROMANELLi 12 Jan 2024 04 Oct 2024 Stefania ALESSI 02 Jun 2023 01 Jun 2024 Matias OLSEN 12 Jan 2024 21 Sep 2024 Victor MAERTENS 15 Jun 2023 15 Jun 2024 Mr Alexander NATZ 01 Apr 2023 30 Mar 2024 Stefano ROMANELLi 20 Jan 2023 12 Jan 2024 Mr Leander VRANKEN 12 Jan 2023 12 Jul 2023 Ms Vittoria Carraro 14 Jul 2022 24 Nov 2022 Mr Dante DI LULIO 10 Jun 2022 10 Jun 2023 Matias OLSEN 10 Jun 2022 10 Jun 2023 Victor MAERTENS 10 Jun 2022 10 Jun 2023 Ms Annarita PIAZZA 05 Feb 2020 18 Jun 2020 Ms Vittoria Carraro 11 Jan 2020 09 Jan 2021 Mr Laurent Louette 09 Oct 2019 09 Oct 2020 Ms Delphine Roulland 08 Dec 2018 01 Jan 2020 Mr Laurent Louette 03 Oct 2018 01 Oct 2019 Ms Delphine Roulland 20 Nov 2017 15 Nov 2018 Mr Alexander NATZ 08 Nov 2016 28 Oct 2017 Ms Delphine Roulland 18 Oct 2016 15 Oct 2017 Mr Oliver Sude 21 Oct 2015 19 Oct 2016 Mr Alexander NATZ 08 Sep 2015 04 Sep 2016 Mr Alexander NATZ 25 Sep 2014 08 Sep 2015 Mr Alexander NATZ 26 Jan 2013 22 Jan 2014 Complementary Information
None declared
Person in charge of EU relations
Data not provided by Register Secretariat due to GDPR
Person with legal responsibility
Data not provided by Register Secretariat due to GDPR
-
Categories
Category
Trade and business associations
-
Networking
Affiliation
Kangaroo group
Member organisations
None declared
-
Financial Data
Interests represented
Promotes their own interests or the collective interests of their members
Closed financial year
Jan 2023 - Dec 2023
Lobbying costs for closed financial year
800,000€ - 899,999€
Major contributions in closed year
None declared
Intermediaries for closed year
Name Amount covington & burling llp 10,000€ - 24,999€ concilius ag 10,000€ - 24,999€ acumen public affairs 25,000€ - 49,999€ fipra international 200,000€ - 299,999€ fti consulting 50,000€ - 99,999€ Intermediaries for current year
Name fipra international concilius ag fti consulting covington & burling llp Closed year Costs
800,000€ - 899,999€
Other financial info
None declared
-
EU Structures
Groups (European Commission)
eHealth Stakeholder Group#E02769#https://ec.europa.eu/transparency/expert-groups-register/screen/expert-groups/consult?lang=en&groupID=2769 #Member #C#Industry, SMEs#Medical Device Coordination Group#X03565#https://ec.europa.eu/transparency/expert-groups-register/screen/expert-groups/consult?lang=en&groupID=3565 #Observer #C#Industry, SMEs#08 - EUDAMED#07 - New Technologies#09 - Unique Device Identification (UDI)#06 - Borderline and Classification (B&C)
Groups (European Parliament)
N/A
Communication activities
EUCOPE’s communication activities include:
- Publishing reports on the policy areas EUCOPE is active in (e.g. reports, position papers, briefing notes, etc) on our website
- Writing and publishing blogs, articles, and podcasts
- Organizing events with both EUCOPE members and external stakeholders
- Dissemination of EUCOPE messages through social media, external newsletters, and traditional media sourcesOther activities
None declared
Meetings
Meetings
22 meetings found. Download meetings
The list below only covers meetings held since November 2014 with commissioners, their cabinet members or directors-general at the European Commission; other lobby meetings with lower-level staff may have taken place, but the European Commission doesn't proactively publish information about these meetings. For more information about which commissioner is responsible for which portfolio, check out this link: https://commissioners.ec.europa.eu/index_en All information below comes from European Commission web pages.
1 July 2024: We have noted that some meetings are appearing in duplicate, ie. some meetings seem to be listed twice. This seems to be because the Commission changes some element of a meeting data after the meeting has first been listed, which causes LobbyFacts to register it as a new meeting. We are investigating further.
-
Date 18 May 2022 Location Brussels, virtual Subject Exchange of views on the upcoming reform of the pharmaceutical legislation Cabinet Cabinet of Commissioner Stella Kyriakides Portfolio Health Attending - Giorgios Rossides (Cabinet member)
- Karolina Herbout-Borczak (Cabinet member)
-
Date 06 Nov 2020 Location Brussels - virtual Subject Videoconference with Pharmaceutical Industry Associations to discuss shortages of medicines and medical devices including diagnostic tests in the context of COVID-19 pandemic Cabinet Cabinet of Commissioner Stella Kyriakides Portfolio Health Attending - Stella Kyriakides (Commissioner)
Other Lobbyists -
Date 30 Sep 2020 Location Online Subject Call with pharmaceutical and medical device supply Chain on COVID-19 Cabinet Cabinet of Commissioner Stella Kyriakides Portfolio Health Attending - Karolina Herbout-Borczak (Cabinet member)
- Giorgios Rossides (Cabinet member)
- Stella Kyriakides (Commissioner)
Other Lobbyists -
Date 29 Jun 2020 Location Online Subject Call with pharmaceutical and medical device industry associations on COVID-19 Cabinet Cabinet of Commissioner Stella Kyriakides Portfolio Health Attending - Karolina Herbout-Borczak (Cabinet member)
- Giorgios Rossides (Cabinet member)
- Stella Kyriakides (Commissioner)
Other Lobbyists -
Date 29 Jun 2020 Location Brussels Subject Videoconference with Pharmaceutical Industry Associations to discuss shortages of medicines and medical devices including diagnostic tests in the context of COVID-19 pandemic Cabinet Cabinet of Commissioner Stella Kyriakides Portfolio Health Attending - Stella Kyriakides (Commissioner)
Other Lobbyists -
Date 29 May 2020 Location Brussels Subject Video call with Pharmaceutical Industrial Associations, the European Medicines Agency and the European Centre for Disease Prevention and Control, to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreak Cabinet Cabinet of Commissioner Stella Kyriakides Portfolio Health Attending - Stella Kyriakides (Commissioner)
Other Lobbyists -
Date 15 May 2020 Location Brussels Subject Video call with Pharmaceutical Industrial Associations, the European Medicines Agency and the European Centre for Disease Prevention and Control, to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreak Cabinet Cabinet of Commissioner Stella Kyriakides Portfolio Health Attending - Stella Kyriakides (Commissioner)
Other Lobbyists -
Date 08 May 2020 Location Brussels Subject Video call with Pharmaceutical Industrial Associations, the European Medicines Agency and the European Centre for Disease Prevention and Control, to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreak Cabinet Cabinet of Commissioner Stella Kyriakides Portfolio Health Attending - Stella Kyriakides (Commissioner)
Other Lobbyists -
Date 08 May 2020 Location Videoconference Subject Video call with Pharmaceutical Industrial Associations, the European Medicines Agency and the European Centre for Disease Prevention and Control, to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreak Cabinet Cabinet of Commissioner Thierry Breton Portfolio Internal Market Attending - Thierry Breton (Commissioner)
Other Lobbyists -
Date 29 Apr 2020 Location Brussels Subject Video call with Pharmaceutical Industrial Associations, the European Medicines Agency and the European Centre for Disease Prevention and Control, to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreak Cabinet Cabinet of Commissioner Stella Kyriakides Portfolio Health Attending - Stella Kyriakides (Commissioner)
Other Lobbyists -
Date 29 Apr 2020 Location Videconference Subject Video call with Pharmaceutical Industrial Associations, the European Medicines Agency and the European Centre for Disease Prevention and Control, to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreak Cabinet Cabinet of Commissioner Thierry Breton Portfolio Internal Market Attending - Thierry Breton (Commissioner)
Other Lobbyists -
Date 23 Apr 2020 Location Brussels Subject Video call with Pharmaceutical Industrial Associations, the European Medicines Agency and the European Centre for Disease Prevention and Control, to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreak Cabinet Cabinet of Commissioner Stella Kyriakides Portfolio Health Attending - Stella Kyriakides (Commissioner)
Other Lobbyists -
Date 23 Apr 2020 Location Videconference Subject Video call with Pharmaceutical Industrial Associations, the European Medicines Agency and the European Centre for Disease Prevention and Control, to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreak Cabinet Cabinet of Commissioner Thierry Breton Portfolio Internal Market Attending - Thierry Breton (Commissioner)
Other Lobbyists -
Date 17 Apr 2020 Location Brussels Subject Video call with Pharmaceutical Industrial Associations, the European Medicines Agency and the European Centre for Disease Prevention and Control, to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreak Cabinet Cabinet of Commissioner Stella Kyriakides Portfolio Health Attending - Stella Kyriakides (Commissioner)
Other Lobbyists -
Date 09 Apr 2020 Location Brussels Subject Video call with Pharmaceutical Industrial Associations and the European Medicines Agency to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreak Cabinet Cabinet of Commissioner Stella Kyriakides Portfolio Health Attending - Stella Kyriakides (Commissioner)
Other Lobbyists -
Date 09 Apr 2020 Location Videoconference Subject Video call with Pharmaceutical Industrial Associations and the European Medicines Agency to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreak Cabinet Cabinet of Commissioner Thierry Breton Portfolio Internal Market Attending - Thierry Breton (Commissioner)
Other Lobbyists -
Date 03 Apr 2019 Location Brussels, Belgium Subject EUCOPE’s presentation and discussion about ongoing EU health files DG Health and Food Safety Attending - Anne Bucher (Director-General)
-
Date 03 Apr 2019 Location Brussels Subject Key aspects of current EU files related to health DG Health and Food Safety Attending - Anne Bucher (Director-General)
-
Date 15 Jun 2018 Location Brussels, Berl Subject HTA Cabinet Cabinet of Commissioner Vytenis Andriukaitis Portfolio Health & Food Safety Attending - Vytenis Andriukaitis (Commissioner)
- Annika Nowak (Cabinet member)
Other Lobbyists -
Date 07 Feb 2018 Location Brussels Subject Supplementary protection certificate; HTA Cabinet Cabinet of Commissioner Vytenis Andriukaitis Portfolio Health & Food Safety Attending - Annika Nowak (Cabinet member)
-
Date 05 Oct 2015 Location BRUSSELS Subject new off-lable rules in France Cabinet Cabinet of Commissioner Elżbieta Bieńkowska Portfolio Internal Market, Industry, Entrepreneurship and SMEs Attending - Rolf Carsten Bermig (Cabinet member)
-
Date 13 Apr 2015 Location Brussels Subject Off-label use of medicines Cabinet Cabinet of Commissioner Vytenis Andriukaitis Portfolio Health & Food Safety Attending - Annika Nowak (Cabinet member)